News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Selexys Pharmaceuticals Corporation Selects Cytovance Biologics for Process Development Services to Accelerate Development Programs



8/1/2007 10:27:49 AM

OKLAHOMA CITY--(BUSINESS WIRE)--Cytovance® Biologics LLC, a biopharmaceutical contract manufacturing company specializing in the production of therapeutic proteins and antibodies from mammalian cell culture, today announced that Selexys Pharmaceuticals Corporation has selected Cytovance for a range of process development services supporting acceleration of its anti-adhesion antibody programs.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES